FDA Site Readiness
for IT & CSV Systems
How VRR Life Sciences transformed a former R&D facility into a fully compliant commercial manufacturing site — with zero FDA 483 observations.
Partner with VRR Life SciencesObservations
Remediation Stages
Doc Cycle Times
Alignment
Critical Compliance Gaps
Blocking Commercial Launch
A global pharmaceutical company acquired a former formulation and development site to convert it into a commercial manufacturing facility for oral solid dosage products — but significant gaps put the entire transition at risk.
While the site had basic procedures in place, critical deficiencies existed across IT infrastructure and computerized systems — none meeting the requirements for FDA commercial inspection under 21 CFR Part 11.
- Missing validation and vendor documentation for critical systems
- Absent audit trails and insufficient data integrity safeguards
- No password complexity rules or unique user ID enforcement
- Personnel lacked formal IT compliance training
- Essential 21 CFR Part 11 controls not implemented
A Three-Phase Compliance Engagement
VRR Life Sciences delivered a structured, phased engagement combining compliance expertise with hands-on remediation — from initial assessment through to sustained monitoring.
- Reviewed site master file, IT SOPs, and full system inventory
- Identified missing validation documentation and vendor records
- Authored and implemented new SOPs for IT management, infrastructure, data backup, and restoration
- Delivered targeted training programs for IT staff and business users
- Conducted 21 CFR Part 11 assessments for all legacy systems
- Implemented immediate procedural controls: unique user IDs, password complexity, and audit trail workarounds
- Updated system inventory and enforced Windows security policies
- Introduced monthly data archival processes and disaster recovery protocols
- Recruited IT administrators and built internal competence for ongoing compliance
- Monitored site performance for two months post-remediation
- Identified and corrected residual compliance gaps
- Strengthened SOPs based on observed operational patterns
- Reinforced compliance culture through retraining and periodic internal audits
Permanent Controls Built to Last
Beyond gap closure, VRR Life Sciences implemented durable compliance infrastructure that remains effective long after project completion.
Measurable Outcomes That Matter
Every defined objective was met — with results that go beyond inspection readiness to build lasting operational resilience.
VRR Life Sciences' experts gave us confidence at every step. They didn't just identify gaps — they built the systems, SOPs, and training that made us inspection-ready. Passing our FDA audit without a single 483 was proof of the rigor they brought.
Compliance-by-Design,
Built for the Long Run
This engagement demonstrates VRR's ability to help life sciences organizations navigate complex regulatory transformations with practical, durable solutions.
-
Deep CSV Expertise Extensive hands-on experience with 21 CFR Part 11, GxP validation, and computerized systems across pharma and biotech.
-
Compliance-by-Design Frameworks Controls and SOPs built for durability — not just to pass the next audit, but to sustain compliance independently.
-
Practical Implementation We don't just report findings — we build the solutions, recruit the talent, and train the teams to make compliance stick.
-
Global Regulatory Reach Trusted by organizations across North America, Europe, and Asia — spanning FDA, EMA, MHRA, and WHO standards.
Ready to Build Your
FDA-Ready Operation?
Partner with VRR Life Sciences for compliance frameworks that hold up under inspection — and beyond.